Продукты

DSM Somos BioClear

    • Название продукта: DSM Somos BioClear
    • Сайт Factroy: Округ Юду, Ганьчжоу, Цзянси, Китай
    • Запрос цены: admin@ascent-chem.com
    • Производитель: Ascent Petrochem Holdings Co., Limited
    • Свяжитесь сейчас
    Спецификации
    Код ТН ВЭД 855604

    Как аккредитованный завод DSM Somos BioClear, мы соблюдаем строгие протоколы качества - каждая партия подвергается строгим испытаниям для обеспечения последовательных стандартов эффективности и безопасности.

    Упаковка и хранение
    Упаковка
    Доставка
    Хранение
    Применение DSM Somos BioClear

    Fabrication of closed-channel cell culture manifolds from DSM Somos BioClear typically begins with layer thickness selection at 25 µm or 50 µm, depending on the smallest channel feature in the fluid path. Where the hydraulic diameter of a perfusion channel falls below 200 µm, the 25 µm build mode is specified to limit interlayer ledging and stair-step occlusion; larger channels above 1 mm may be produced at 50 µm to reduce laser scan time without affecting burst-pressure requirements. Drainage of uncured resin from blind via holes below 0.5 mm diameter is assisted by orienting the part at 15–20° from horizontal and by applying a short air pulse of 0.5–1.0 bar after the build platform lifts. Support contact points are restricted to non-functional surfaces and reduced to 0.2–0.3 mm contact diameter to avoid chipping during removal.

    Green parts are transferred immediately to a two-stage wash using 99.9% 2-propanol, with the first bath in a 35–40 kHz ultrasonic tank at 23 ± 2 °C for 5 min and the second in fresh solvent under agitation for 2 min; a final rinse in deionized water for 60 s removes solvent residue from low-diameter channels. Post-cure is performed in a 365–405 nm LED chamber at 10–20 mW/cm² with the part heated to 60 °C for 40 min. The cure temperature is held below the dry heat deflection temperature to protect flatness of the bonding face while still accelerating conversion of residual acrylate groups at the channel wall. After post-cure, parts are dry-heated at 45 °C for 2 h to remove absorbed moisture before adhesive lamination.

    For cell-contact microfluidic cartridges, the material is selected only after cytotoxicity testing according to ISO 10993-5:2009 with L929 fibroblasts, and the evaluation plan is documented under ISO 10993-1:2018 for a limited-exposure surface-contacting device. Leachable reduction is performed by soaking in sterile phosphate-buffered saline at 37 °C for 7 days with complete replacement of the soak solution every 24 h; residual solvent concentration is monitored by headspace GC-MS and must be below the reporting limit specified in the device master file. Finished products are typically closed-channel flow cells with channel widths of 0.1–0.5 mm, a glass or cyclo-olefin polymer lid bonded to the BioClear base, and 1/4-28 threaded ports for fluidic interconnection.

    What Changes When BioClear Replaces Machined PMMA in Hearing Aid Shell Production?

    The replacement of milled PMMA with stereolithographic BioClear in custom in-the-ear shells shifts process control from toolpath compensation to build orientation, support contact, and post-cure geometry. Production builds use 50 µm layers for most shell geometries, but the faceplate rim is oriented at 30–35° from vertical to distribute the interlayer step pattern away from the acoustic sealing plane. Wall thickness is maintained between 0.6 mm and 0.8 mm, with minimum spot face thickness of 0.5 mm at vent apertures; this avoids flexural failure during insertion while retaining sufficient translucency for technician inspection.

    After build, shells are washed in two sequential 99.9% isopropanol baths, dried at 23 °C for 30 min, and UV post-cured at 60 °C for 30 min in a nitrogen-purged chamber. The nitrogen purge reduces surface tack caused by oxygen inhibition at the acrylate surface. Shells are conditioned for 24 h at 23 ± 2 °C and 50 ± 5% relative humidity before any dimensional audit, because water uptake during humid storage can change vent-bore diameter by up to 0.05 mm. Finishing uses ceramic tumble media of 0.5 mm spheres for 4 h, followed by hand polishing of the faceplate rim; the target surface roughness is Ra 0.8 µm or lower before clear lacquer is applied.

    Biocompatibility for skin-contacting shells is supported by ISO 10993-5:2009 and ISO 10993-10:2010 data. Disinfection is limited to 70% ethanol wipes or cold sterilant; autoclaving is not permitted because exposure above 50 °C can produce measurable distortion of the acoustic vent. In production lots of 500 shells, acoustic vent diameter is held to ±0.08 mm with a 0.8–1.2 mm nominal bore, and shell-to-shell wall thickness variance is controlled by weekly laser power calibration of the SLA machine.

    When clear implant drilling guides are required, the use of BioClear is constrained by intraoral contact duration, rotational torque, and the retention of stainless steel drill sleeves. The guide is designed from CBCT DICOM data with sleeve holes matched to guided drills of 2.2 mm, 2.8 mm, or 3.5 mm diameter; the printed resin must maintain bore concentricity within 0.05 mm after post-cure, because a metallic sleeve inserted into an ovalized bore can cause angular deviation at the osteotomy.

    Build thickness is set to 50 µm, and the guide is oriented with sleeve bores vertical to the build platform to avoid elliptical distortion from layer offset. After printing, uncured resin is flushed from each bore with isopropanol using a syringe at 1.0–1.5 bar, then the part is post-cured at 40 °C for 60 min rather than 60 °C; the lower cure temperature reduces thermal stress that can change inter-sleeve centre distances. Titanium or stainless steel sleeves with an outside diameter of 3.0 mm or 4.2 mm are fixed with a light-cure adhesive, with 20 s exposure at 405 nm per sleeve. Final bores are checked with go/no-go pin gauges.

    Short-term intraoral use is assessed under ISO 10993-5:2009 for cytotoxicity and ISO 10993-10:2010 for irritation; if contact exceeds 30 min, sensitization documentation is added to the biological evaluation plan. Sterilization is performed by immersion in a validated cold sterilant rather than autoclave, because repeated thermal excursion above 50 °C may shift bore concentricity beyond the allowed 0.05 mm. The terminal component is a clear, rigid drilling guide with embedded metal sleeves, used for positional transfer of planned implant trajectories.

    Application scenarioContact categoryPrimary standards
    Microfluidic cell culture manifoldLimited-exposure surface contactISO 10993-1:2018; ISO 10993-5:2009
    Hearing aid shellSkin contact, prolongedISO 10993-5:2009; ISO 10993-10:2010
    Implant drilling guideIntraoral short-termISO 10993-5:2009; ISO 10993-10:2010
    Optical windowNon-patient contactASTM D1003-21; RoHS Directive 2011/65/EU
    Silicone overmolding masterNon-patient contact toolingISO 13485:2016; ISO 80369-7:2016
    Diagnostic cartridgeNon-invasive IVD fluid pathREACH (EC) No 1907/2006; RoHS Directive 2011/65/EU

    Optical Cuvette Windows in Benchtop Analyzers

    For optical windows integrated into benchtop clinical chemistry analyzers, BioClear is processed to minimise haze and internal scattering rather than to meet cell-contact requirements. Flat window blanks are printed at 25 µm layers, then machined on two faces by single-point diamond turning at a feed rate of 5 µm/rev and depth of cut of 2 µm to remove the laminar build signature. After machining, progressive lapping with 9 µm, 3 µm, and 1 µm diamond slurries produces a surface roughness below 0.02 µm Ra over a 10 mm aperture.

    Post-cure for optical components is extended to 60 min at 60 °C under 365 nm UV with irradiance of 20 mW/cm², because incomplete through-thickness conversion creates sub-surface density gradients that become visible as striae under dark-field inspection. For a 2 mm polished section, the analyzer platform specification requires haze below 5% and total luminous transmittance above 85%, measured under ASTM D1003-21 with a D65 illuminant and 10° observer. RoHS compliance is documented under Directive 2011/65/EU as amended by Delegated Directive (EU) 2015/863, and the finished optical window is placed in the sample light path after 100% visual inspection under dark-field illumination.

    In low-volume catheter assembly production, BioClear SLA masters are used as core mandrels for room-temperature vulcanizing silicone overmolding. The master is printed with 25 µm layers to preserve the tapered luer geometry, and the critical sealing face is polished with 3 µm diamond paste until the surface roughness is below 0.1 µm Ra. A water-soluble release film is applied by dipping the master in a 2% w/v polyvinyl alcohol solution and drying at 35 °C for 30 min; this prevents the platinum-cured silicone from bonding to the acrylate surface and enables clean demoulding without solvents.

    Two-part platinum-cured silicone is mixed at 1:1 by weight and degassed at -0.95 bar for 5 min before pouring; the silicone cures at 23 °C for 24 h with no oven heating, so the BioClear master is not exposed to temperatures near its heat deflection limit. After demoulding, residual polyvinyl alcohol is removed by warm deionized water immersion for 15 min. The BioClear master is reused until dimensional audit of the luer tip exceeds 0.02 mm deviation from the nominal CAD geometry, after which the master is retired from production.

    Because the finished silicone component is the patient-contacting material, its luer geometry is checked under ISO 80369-7:2016 with standard gauges, while the BioClear master is governed by dimensional controls under ISO 13485:2016. The terminal product is a low-volume silicone catheter manifold or luer-equipped component produced without high-temperature injection mould tooling.

    When Post-Cure Through-Thickness Conversion Determines Bond Strength

    Multi-layer diagnostic cartridges built from BioClear and cyclo-olefin polymer film require laminating adhesives to be applied only after the SLA part has reached sufficient through-thickness conversion. In production, flat coupons of 2 mm thickness are post-cured for 30 min, 45 min, and 60 min at 60 °C, then examined by ATR-FTIR at the bond interface for the residual acrylate absorption near 810 cm⁻¹. Bond strength is considered acceptable only when the integrated peak area has decreased by at least 85% relative to the green state; if the 30 min process does not reach this threshold, the post-cure duration is extended and the lot is re-qualified.

    Adhesive lamination is performed with a UV-curable acrylate adhesive applied at 5–8 g/m² through a slot die coater, with lamination pressure held at 0.2 MPa for 30 s. The assembled cartridge is leak-tested at 1.5 bar internal air pressure for 30 s while submerged in water; any bubble release at the BioClear-to-film interface is a reject criterion. This is a practical alternative where published data for the specific adhesive configuration is limited; the leak threshold is derived from the IVD platform's maximum operating pressure of 1.0 bar plus a 50% safety margin.

    Electrical and electronic components in the cartridge are outside the patient body, so the material file references RoHS Directive 2011/65/EU and REACH Regulation (EC) No 1907/2006 rather than an implant-level biological evaluation. The terminal product is a sealed, transparent reaction cartridge with an internal calibration channel and barcode-mapped lot traceability.

    For oncological resection planning in maxillofacial surgery, transparent anatomical models are produced from BioClear to visualise the spatial relationship between the tumour, nerve canals, and roots. The segmented model is printed at 100 µm layers with a wall thickness of 2 mm, and the medullary space is left hollow to reduce resin consumption while maintaining rigidity. After printing, the model is rinsed in isopropanol and post-cured for 30 min at 60 °C; internal cavities are drained through 1 mm vent holes that are later sealed with clear silicone adhesive.

    Surface disinfection before entering the surgical planning room uses a 70% ethanol wipe, which is compatible with the cured resin for repeated contact at 23 °C. The model is not intended for implantation or intraoral use, so biocompatibility testing under ISO 10993 is not required for this application; instead, dimensional accuracy is verified against the CT dataset at three landmark points with a maximum deviation of ±0.5 mm. The finished product is a transparent planning model with coloured internal tumour volume, used by the surgical team for pre-operative access planning.

    Бесплатная цитата

    Конкурентные цены DSM Somos BioClear, которые соответствуют вашему бюджету - гибкие условия и индивидуальные котировки для каждого заказа.

    Для получения образцов, цен или более подробной информации свяжитесь с нами по адресу +8618136850665 или отправить по почте admin@ascent-chem.com.

    Мы ответим вам как можно скорее.

    Телефон: +8618136850665

    Электронная почта: admin@ascent-chem.com

    Запрос

    Получите бесплатную сметуAscent Petrochem Holdings Co., Limited

    Гибкие условия оплаты, конкурентоспособные цены, первоклассное обслуживание — обращайтесь прямо сейчас!

    Сертификация и соответствие требованиям
    Более подробное введение

    DSM Somos BioClear

    DSM Somos BioClear is a clear, low-viscosity stereolithography resin supplied for vat photopolymerization systems operating principally with 355 nm UV laser sources. The material is specified where short-term tissue- or fluid-contact devices require optical transparency combined with biocompatibility screening data rather than the property profile of an inert thermoplastic substitute. Standard builds use 50 µm or 100 µm layer thickness on laser-galvanometer platforms; published processing data for masked DLP or LCD systems is limited because the resin was validated primarily on scanning-laser equipment. The product is sold under the Somos brand with safety data sheets addressing REACH registration and RoHS substance restrictions for the European market, but the material is not presented by the supplier as a food-contact resin. Unpigmented parts are water-clear after post-cure, yet the cured network is glassy and semi-rigid rather than elastomeric, so design rules must account for low elongation and notch sensitivity.

    What Are the Typical Mechanical and Thermal Property Bounds?

    Cured-resin values reported under standard test methods are compiled in Table 1. The tensile response places BioClear in the semi-rigid clear SLA class: tensile strength falls within 45–50 MPa, tensile modulus within 2.2–2.5 GPa, and elongation at break between 6% and 12%. The notched Izod impact range of 25–32 J/m indicates that thin walls, snap-fit features, and sharp internal corners can fail during support removal or service if local stress concentrations exceed the material’s limited plastic deformation capacity. The heat deflection temperature at 0.46 MPa of 46–52 °C defines the upper thermal boundary for load-bearing components; service above this range under mechanical load is outside documented performance. Water absorption at 24 h of 0.30–0.40% is comparatively low for a clear photopolymer network, but dimensional change in humid environments should still be evaluated according to ISO 62:2008 when mating clear components with rigid housings.

    Table 1. Representative cured-resin property ranges for DSM Somos BioClear compiled from supplier datasheet values.
    PropertyTest methodReported value
    Tensile strengthASTM D638-1445–50 MPa
    Tensile modulusASTM D638-142.2–2.5 GPa
    Elongation at breakASTM D638-146–12%
    Flexural strengthASTM D790-1765–75 MPa
    Flexural modulusASTM D790-172.0–2.3 GPa
    Notched Izod impactASTM D256-1025–32 J/m
    HardnessASTM D2240-1584–86 Shore D
    Heat deflection temperature at 0.46 MPaASTM D648-1846–52 °C
    Water absorption at 24 hASTM D570-980.30–0.40%
    DensityASTM D792-201.13 g/cm³
    Dynamic viscosity at 30 °CBrookfield LV250–350 cP

    The low uncured viscosity of 250–350 cP at 30 °C improves recoat speed on laser-galvanometer stereolithography systems compared with filled biocompatible resins. However, viscosity is temperature-sensitive. In production vats, cooling below 25 °C increases resin layer thickness during recoating and can produce under-cured sidewalls because the wet film is thicker than the intended slice. Conversely, operation above 35 °C accelerates dark polymerization and shortens pot life. Industrial users report that exposure working curves should be re-established when switching resin lots because inhibitor concentration can shift slightly with storage conditions and age, causing batch-to-batch variation in cure depth even when laser power remains stable. A build chamber held at 28–30 °C is typical for maintaining consistent recoating behavior without aggressive thermal aging of the vat.

    Optical Clarity, Refractive Index, and Surface Finish

    Post-cured parts are water-clear only after surface finishing; as-built vertical surfaces retain layer striations that scatter light and reduce optical contrast. The supplier does not list a bulk haze value under ASTM D1003-13 because surface roughness dominates the measured scatter in layered stereolithography parts. Low-angle build orientations create stair-step boundaries that require sanding, polishing, or clear-coat application before transmission optics are attempted. Thin transparent windows built at 50 µm layers exhibit lower step height than 100 µm layers, but build time increases nonlinearly because recoating and laser path coverage occupy a larger fraction of the cycle.

    Independent evaluations place the cured refractive index near 1.50 at the sodium D line, but published supplier data for refractive index dispersion is limited. When optical modelling is required for lensing or total internal reflection channels, the refractive index should be measured on a post-cured specimen using an Abbe refractometer because cure dose, water uptake, and residual solvent all shift the value. Yellowing is minimal under standard UV post-cure, but thermal post-cure above 80 °C and gamma sterilization above 25 kGy can produce a measurable yellow shift. Optical validation after sterilization is therefore mandatory for clear diagnostic windows or color-sensitive detection paths.

    Biocompatibility screening for DSM Somos BioClear is documented under short-term contact classifications. The supplier’s regulatory file references cytotoxicity evaluation per ISO 10993-5:2009, intracutaneous irritation and skin sensitization per ISO 10993-10:2010, and USP Class VI biological reactivity per USP <88>. These data support external communicating devices and limited tissue-contact applications, not permanent implantation. Under ISO 10993-1:2018, the final device manufacturer must complete a biological evaluation for the finished geometry, process history, and sterilization pathway; resin-level certification alone does not confer device-level approval. The material is not characterized for blood-contact circuits, long-term implantation, or drug-delivery reservoirs with prolonged residence time. Table 2 summarizes the compliance scope.

    Table 2. Biocompatibility and processing compliance scope for DSM Somos BioClear.
    AssessmentReferenceScope
    CytotoxicityISO 10993-5:2009Supplier file reports pass for L929 fibroblast extracts
    IrritationISO 10993-10:2010Intracutaneous reactivity; no greater than control
    SensitizationISO 10993-10:2010Guinea pig maximization; no sensitization
    Systemic injectionUSP <88>Class VI plastics classification
    Long-term implantationISO 10993-1:2018Not characterized; device-level evaluation required
    Sterilization compatibilityISO 17665-1:2006, ISO 11135:2014, ISO 11137-1:2006EO and gamma feasible; steam requires stress-free fixturing

    The resin is not a direct substitute for implantable-grade polymers such as medical PEEK or UHMWPE. Its biocompatibility file is relevant to short-term tissue contact, diagnostic housings, and externally communicating components, but the network contains leachable low-molecular-weight species unless post-processing is controlled. Leachables evaluation under ISO 10993-18:2020 should be performed when the cured part contacts drug-containing fluids, mucosal tissue, or repeated-use skin surfaces. The absence of a long-term implantation qualification is an operational boundary, not a processing defect, and design controls should reflect that boundary.

    When Sterilization Is Required, What Changes in Part Design?

    Steam sterilization at 121 °C standard cycle exceeds the documented heat deflection temperature at 0.46 MPa. Load-bearing features must be fixtured during autoclave to avoid creep, and rapid exhaust should be avoided because pressure differentials can craze thin transparent walls. Validation should follow ISO 17665-1:2006 for moist heat unless the device cannot tolerate the thermal excursion. Because the material absorbs less than 0.40% water at 24 h, moisture-induced expansion is limited but not zero; repeated autoclave cycling can still shift interference fits and optical alignment.

    Ethylene oxide processing per ISO 11135:2014 is the common lower-temperature route. ETO is absorbed into the glassy network, and extended aeration at 45–50 °C is required to reduce residual gas below device-specific limits. Gamma irradiation per ISO 11137-1:2006 at 25 kGy typically yellows the part and may increase tensile modulus by additional crosslinking while reducing elongation at break. Post-sterilization mechanical testing per ASTM D638-14 should be performed on specimens from each build orientation because anisotropic layer interfaces can respond differently to radiation-induced crosslinking. Published data for higher gamma doses above 25 kGy is limited, so dose audits should include optical and mechanical acceptance criteria.

    When Layer Thickness Changes from 100 µm to 50 µm, Green Strength Is Not Halved

    Because cure depth follows the Jacobs working curve, reducing layer thickness from 100 µm to 50 µm does not halve the required laser exposure; the relationship is logarithmic and includes a critical exposure threshold. The penetration depth at 355 nm is machine-specific and must be determined by exposure tests on each laser-galvanometer platform. Green-state flexural stiffness at 50 µm is lower in absolute terms, but the finer layer interface reduces mechanical anisotropy and improves sidewall quality in microfluidic channels. Production-scale stereolithography platforms using a recoater blade gap of 0.10–0.15 mm report more stable recoating with BioClear than with highly filled resins, because the low viscosity promotes leveling. However, low temperature operation below 20 °C can produce support delamination and under-cured sidewalls because the photoinitiator response and recoating thickness both shift. The practical process window is bounded by low-temperature viscosity increase and high-temperature dark polymerization rather than by post-cure kinetics alone.

    Residual Monomer Migration and Solvent Compatibility Establish the Post-Cure Window

    Green-state parts contain unreacted acrylate and methacrylate species that must be removed before skin contact. The supplier-recommended rinsing sequence uses tripropylene glycol monomethyl ether followed by isopropanol; ultrasonic agitation should be limited to short duration because cavitation can initiate microcracks in unsupported thin sections. Ketones, chlorinated solvents, and strongly alkaline cleaners are incompatible and produce surface crazing or stress whitening. After rinsing, parts are dried at 40–50 °C for at least 2 h before UV post-cure to reduce residual solvent retention. The post-cure chamber should emit in the 365–405 nm range and maintain part temperature below 60 °C unless thermal aging is separately validated. Higher post-cure temperatures accelerate conversion but risk yellowing and warp in asymmetric geometries. In high-humidity production environments above 60% RH, desiccant air handling is recommended because residual monomer migration can increase surface tack and interfere with clear-coat adhesion.

    Contrasting DSM Somos BioClear with Non-Biocompatible Clear Stereolithography Resins

    The central differentiator is regulatory documentation. General-purpose clear SLA resins may provide similar optical clarity or slightly higher elongation, but they are not supplied with USP Class VI or ISO 10993 biological reactivity screening. Somos WaterShed XC 11122 provides water-resistant clarity for flow models and consumer packaging prototypes, but it is not marketed with a biocompatibility file for medical device body contact. BioClear is therefore selected when the part must enter a design history file under ISO 13485:2016 and requires a resin-level biological evaluation package. The trade-off is thermal and impact performance: BioClear’s heat deflection temperature of 46–52 °C is lower than some engineering SLA grades, and its elongation at break below 12% is less forgiving of snap-fit designs.

    Switching from a non-biocompatible clear resin to BioClear requires process changes beyond resin substitution. The photoinitiator package shifts the exposure working curve, and support removal is slightly more prone to fracture because the cured network is optimized for controlled extractables and biological end use rather than maximum toughness. Industrial comparisons show that BioClear recoats faster than filled biocompatible SLA resins due to its lower viscosity, but it produces less green-state stiffness for large overhangs. Published direct comparative mechanical data between BioClear and WaterShed XC 11122 is limited; side-by-side coupons should be printed on the same machine when a replacement qualification is required. The selection should be recorded as a raw-material change under the device manufacturer’s quality system, with re-verification of dimensional accuracy, optical clarity, and biological evaluation according to the finished device risk class.

    In microfluidic and short-term diagnostic device fabrication, BioClear is typically built at 50 µm layers to reduce channel wall roughness. Open channels may require solvent polishing with tripropylene glycol monomethyl ether or a clear UV-curable coating to achieve optical access; any coating or adhesive contacting tissue or fluid must be separately assessed under ISO 10993-1:2018. Unpigmented BioClear has been used for optical detection windows because its fluorescence background is lower than pigmented SLA resins, although published excitation-emission matrices for this specific configuration are limited. Flow-path surfaces intended for drug-containing fluids should undergo leachables testing under ISO 10993-18:2020 because the resin network is not inert and residual low-molecular-weight species may migrate under continuous wet contact. Edge-bonded assemblies using ultraviolet-cured adhesives should be validated for burst pressure and channel dimensional stability, since the semi-rigid network can creep at temperatures above 45 °C when pressurized.

    ТОП